(2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide

C20H21N5O4S — CID 58441018

IUPAC(2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide
SMILESCOc1cc(N2CCc3nc(NC(=O)[C@H](O)c4ccccc4)sc3C2)nc(OC)n1
InChIInChI=1S/C20H21N5O4S/c1-28-16-10-15(22-19(23-16)29-2)25-9-8-13-14(11-25)30-20(21-13)24-18(27)17(26)12-6-4-3-5-7-12/h3-7,10,17,26H,8-9,11H2,1-2H3,(H,21,24,27)/t17-/m1/s1
InChIKeySMAJHSWAQVKAEN-QGZVFWFLSA-N
MW427.49 g/mol
LogP2.19
Rot. Bonds6

About (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide

(2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide (PubChem CID 58441018) has the molecular formula C20H21N5O4S and a molecular weight of 427.49 g/mol. Its IUPAC name is (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide.

Molecular Properties

Compound Name(2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide
PubChem CID58441018
Molecular FormulaC20H21N5O4S
Molecular Weight427.49 g/mol
Exact Mass427.13
IUPAC Name(2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide
SMILESCOc1cc(N2CCc3nc(NC(=O)[C@H](O)c4ccccc4)sc3C2)nc(OC)n1
InChIInChI=1S/C20H21N5O4S/c1-28-16-10-15(22-19(23-16)29-2)25-9-8-13-14(11-25)30-20(21-13)24-18(27)17(26)12-6-4-3-5-7-12/h3-7,10,17,26H,8-9,11H2,1-2H3,(H,21,24,27)/t17-/m1/s1
InChIKeySMAJHSWAQVKAEN-QGZVFWFLSA-N
XLogP2.19
TPSA109.70 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500427.49
LogP ≤ 52.19
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide?
The IUPAC name of (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide (CID 58441018) is (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide.
What is the SMILES notation for (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide?
The canonical SMILES for (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide is COc1cc(N2CCc3nc(NC(=O)[C@H](O)c4ccccc4)sc3C2)nc(OC)n1.
What is the InChIKey of (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide?
The InChIKey is SMAJHSWAQVKAEN-QGZVFWFLSA-N. The full InChI is InChI=1S/C20H21N5O4S/c1-28-16-10-15(22-19(23-16)29-2)25-9-8-13-14(11-25)30-20(21-13)24-18(27)17(26)12-6-4-3-5-7-12/h3-7,10,17,26H,8-9,11H2,1-2H3,(H,21,24,27)/t17-/m1/s1.
What are the key properties of (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide?
(2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide has a molecular weight of 427.49 g/mol, XLogP of 2.19, 6 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[5-(2,6-dimethoxypyrimidin-4-yl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-2-hydroxy-2-phenylacetamide is sourced from PubChem (CID 58441018), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).